Key Highlights
- SK Hynix debuted its American Depositary Receipts at $149, securing $26.5 billion in capital
- Institutional demand totaled approximately $171.5 billion — exceeding available shares by 7x
- Major investors including Coatue, Baillie Gifford, and Situational Awareness signaled interest totaling $7 billion
- Barclays launched coverage with Overweight rating and $330 target — suggesting ~117% potential gain from $152.35
- Analyst forecasts 35% DRAM demand expansion in 2027 against only 20% supply increase
SK Hynix (SKHY) stock has been changing hands around $186 following its Wall Street debut last week, after the company set its ADR price at $149 per share — and analysts are already weighing in aggressively.
During the bookbuilding phase, aggregate orders approached $171.5 billion. Given the 177.9 million ADRs available, demand outstripped supply by more than sevenfold. The majority of interested buyers received allocations well below their requested amounts.
Three prominent institutional investors — Coatue Management, Baillie Gifford, and Situational Awareness — expressed combined interest approaching $7 billion. The offering also attracted sovereign wealth funds, technology-focused investment vehicles, and international institutional managers.
Such overwhelming enthusiasm stands out, particularly considering market conditions at the time.
Memory semiconductor equities — encompassing both SK Hynix’s Korean-listed shares and Micron — had declined into bear territory during the days preceding the American listing. Market participants were dumping the sector amid concerns about cyclical peaks, despite strong quarterly results from competitors. Yet major institutions were simultaneously committing billions to SK Hynix’s US offering.
Barclays Launches Coverage With Bullish $330 Price Target
Barclays launched its coverage this Tuesday with an Overweight recommendation and $330 price objective, representing potential appreciation of approximately 117% from Monday’s closing price of $152.35.
Analyst Simon Coles contends that DRAM supply constraints will intensify throughout 2027, with bit supply expansion of roughly 20% annually projected to significantly lag demand acceleration to 35%. His analysis suggests this supply-demand imbalance will extend for multiple years.
Regarding SK Hynix particularly, Coles anticipates the firm will maintain its dominant position in high-bandwidth memory (HBM). He stated that apparent technological gaps versus Samsung should be “neutralised by HBM4E,” with SK Hynix preserving over 50% HBM market share well into the future.
Coles additionally highlighted an evolving investment thesis centered on shareholder returns. His estimates indicate SK Hynix will accumulate cash representing more than 40% of its present market capitalization by 2027’s conclusion, providing substantial capacity for share repurchases. Under a hypothetical $50 billion buyback scenario, Barclays projects double-digit earnings per share growth in 2028 — even assuming stable or slightly declining average selling prices.
Chinese Competition: Emerging but Contained Near-Term
Coles acknowledged that Chinese memory manufacturers are progressing rapidly. China’s leading DRAM producer elevated its DDR5 yield above 75% by late 2025, with bit shipment volumes estimated to have climbed 55% year-over-year in 2025 and projected to rise 48% in 2026.
However, he views the immediate global competitive impact as manageable. Any Chinese market share gains beyond domestic borders would liberate merely 1-4% of combined manufacturing capacity across Samsung, SK Hynix, and Micron. Additionally, China’s HBM3 technology development continues to lag, with volume production likely postponed until 2027.
The American listing generated approximately $26.5 billion according to regulatory disclosures, positioning it among the largest capital raises in recent years.
Barclays’ $330 valuation target represents the inaugural formal Street analysis on the ADRs since trading commenced.





